West Paces Advisors’s Bruker BRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-41
Closed -$2.57K – 528
2022
Q2
$2.57K Hold
41
– – ﹤0.01% 472
2022
Q1
$2.64K Hold
41
– – ﹤0.01% 473
2021
Q4
$3.44K Buy
41
+4
+11% +$321 ﹤0.01% 469
2021
Q3
$2.89K Hold
37
– – ﹤0.01% 468
2021
Q2
$2.81K Buy
+37
New +$2.58K ﹤0.01% 489

Other funds holding BRKR

West Paces Advisors's BRKR Position: Q3 2022 in Review

West Paces Advisors sold out of Bruker (BRKR) in Q3 2022, closing a stake of 41 shares — an estimated $2.57K sold.

West Paces Advisors first reported a position in BRKR in Q2 2021 and held it in 5 quarters. The position peaked at $3.44K in Q4 2021. 280 funds tracked by Wall St. Rank hold BRKR as of Q3 2022.

  • West Paces Advisors reported no remaining Bruker position as of Q3 2022 after selling out during the quarter.
  • West Paces Advisors sold 41 Bruker shares in Q3 2022, an estimated $2.57K.
  • West Paces Advisors first reported a position in Bruker in Q2 2021 and held it in 5 quarters.
  • West Paces Advisors's Bruker position peaked at $3.44K in Q4 2021.
  • 280 funds tracked by Wall St. Rank held Bruker as of Q3 2022.

Based on West Paces Advisors's 13F filing for Q3 2022, filed 19 Dec 2023.